Jazz Pharmaceuticals PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
57.89 M |
Public Float |
- |
Jazz Pharmaceuticals PLC | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$8.02 |
Market Cap |
$7.99 B |
Shares Outstanding |
56.64 M |
Public Float |
55.03 M |
Address |
Waterloo Exchange Dublin Dublin 4 Ireland |
Employees | - |
Website | http://www.jazzpharma.com |
Updated | 07/08/2019 |
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. |